Genetic detection of colorectal cancer cells in circulation and lymph nodes

Diseases of the Colon and Rectum

Volumn 40, Issue 10 SUPPL., 1997, Pages

  Nakamori, Shoji ^a   Kameyama, Masao ^b   Furukawa, Hiroshi ^b   Takeda, Osamu ^c   Sugai, Sachiko ^d   Imaoka, Shingi ^b   Nakamura, Yusuke ^a,e  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c Takara Advanced Biomedical Center   (Japan)

^d CANCER INSTITUTE   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Circulating tumor cells; Colorectal cancer; Cytokeratin; Genetic diagnosis; Lymph node metastasis; Micrometastasis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; GENE LOCATION; GENE MUTATION; HUMAN; LYMPH NODE METASTASIS; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

COLORECTAL NEOPLASMS; FEMALE; GENES, P53; GENES, RAS; HUMANS; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; POLYMERASE CHAIN REACTION; RNA; TUMOR MARKERS, BIOLOGICAL;

EID: 0030769076     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02062017     Document Type: Article

References (24)

1. Gastrointestinal Tumor Study Group. Adjuvant therapy of colon cancer - results of a prospectively randomized trial. N Engl J Med 1984;310:737-43.
2. National Institutes of Health Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1447-50.
3. O'Connel MJ, Schaid DJ, Ganju V, Cunningham J, Kovach JS, Thibodeau ST. Current status of adjuvant chemotherapy for colorectal cancer. Cancer 1992;70: 1732-9.
4. Fidler IJ: The evolution of biological heterogeneity in metastatic neoplasms. In: Nicolson GL, Milas L, eds. Cancer invasion and metastasis: biologic and therapeutic aspects. New York: Raven Press, 1984:5-30.
5. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalogue of human cytokeratins: patterns of expression in normal epithelia, tumours and cultured cells. Cell 1982;31:11-24.
6. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 1994;12:475-82.
7. Krismann M, Todt B, Schröder J, et al. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 1995;13:2769-75.
8. Soeth E, Röder C, Juhl H, Krüger U, Kremer B, Kalthoff H. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer 1996;69:278-82.
9. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;71:278-81.
10. Takeda S, Ichii S, Nakamura Y. Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA). Hum Mutat 1993;2:1115-20.
11. Hayashi N, Arakawa H, Nagase H, et al. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method. Cancer Res 1994; 54:3853-6.
12. Hayashi N, Ito I, Yanagisawa A, et al: Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 1995;345:1257-9.
13. Harmanek P, Sobin LH, eds. TNM classification of malignant tumors. 4th ed. Berlin: Springer-Verlag, 1987.
14. Maniatis T, Fritsh EF, Sanbrook J, eds. Molecular cloning: a laboratory manual. 1st ed. New York: Cold Spring Harbor Laboratory, 1982.
15. Miyoshi Y, Nagase H, Ando H, et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in APC gene. Hum Mol Genet 1992;1:229-33.
16. Glavies D, Huben RP, Weiss L. Haematogenous dissemination of cells from human renal adenocarcinomas. Br J Cancer 1988;57:32-5.
17. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;335: 1565-8.
18. Cutait R, Alves VA, Lopes LC, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991;34: 917-20.
19. Mascarel I, Bonichon F, Coindre JM, et al. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 1992;66:523-7.
20. Schoenfeld A, Luqmani Y, Smith D, et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 1994; 54:2986-90.
21. Noguchi S, Aihara T, Nakamori S, et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 1994;74:1595-600.
22. Mori M, Mimorti K, Inoue H, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1995; 55:3417-20.
23. Bos JL. Ras oncogenes in human cancer: a review. Cancer 1989;49:4682-9.
24. Levine AJ, Momand J, Finaly CA. The p53 tumor suppresser gene. Nature 1991;358:453-7.